Skip to main content

Table 1 Baseline Demographic and Clinical and Radiological Characteristics at Cerebral Venous Thrombosis (CVT) presentation

From: Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer

Characteristic N (%)
Male 25(55.6 %)
Age (years) Median, [IQR] 54.5, [41.5,62.4]
Body Mass Index (Kg/m2) Median, [IQR] 27.2, [23.4, 33.4]
Malignancy type
 Hematologic 15 (33.3 %)
 Solid 24 (53.3 %)
 Primary CNS 5 (11.1 %)
 Concurrent solid and CNS 1 (2.2 %)
Malignancy status
 Active 32 (71.1 %)
 Remission < 2 years 8 (17.8 %)
 Remission > 2 years 4 (8.9 %)
Staging (AJCC)
 1 8 (17.8 %)
 2 4 (8.9 %)
 3 5 (11.1 %)
 4 17 (37.8 %)
Active chemotherapy 20 (44.4 %)
Hormonal cancer therapy 4 (8.9 %)
Tyrosine kinase inhibitor 1 (2.2 %)
Use of ESA 1 (2.2 %)
Recent major surgery 27 (60.0 %)
Multifocal CVT 26 (57.8 %)
Occlusive CVT 14 (31.1 %)
Concurrent brain venous infarction 12 (26.7 %)
Concurrent brain parenchyma hemorrhage 16 (35.6 %)